Atlas Trials

A Study of Ivabradine in African-American/ Black Subjects With Heart Failure and Left Ventricular Systolic Dysfunction.

Clinical trial NCT03456856 · COMPLETED

Trial details

NCT number
NCT03456856
Sponsor
Amgen
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Heart Failure (HF)
Start date
2017-09-28
Primary completion
2019-04-19
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.